Announcements Trials
Browse Landscape

Phase

Phase NA 5Phase 2 5Phase 3 4Phase 1/2 2Phase 4 1Phase 1 1

Status

Unknown 3Terminated 1

Sponsor Class

OTHER 87INDUSTRY 86NIH 17NETWORK 15OTHER_GOV 4

Study Type

Interventional 4

Sponsor

Cancer Type

Gastrointestinal 42Gynecologic 29Breast 23Thoracic 15Head & Neck 12Other hematologic neoplasm 7Lymphoid 6CNS 5Plasma cell 4Myeloid 4Genitourinary 4Dermatologic 3Tumor-Agnostic 2Other 2Endocrine 2Sarcoma 1Other solid neoplasm 1Other neoplasm 1NET 1Classical hematology 1

Conditions

Leukemia, Myelogenous, Chronic, BCR-ABL Positive 3Myelodysplastic Syndromes 1Leukemia, Myeloid, Acute 1

Interventions

peginterferon alfa-2a 1Imatinib Mesylate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Phase 3 × OTHER_GOV × Myeloid × Clear all
NCT03746054 2025-03-17

PALERMO

University Hospital, Angers

Phase 3 Terminated
80 enrolled
MyeloidOther hematologic neoplasm

Leukemia, Myelogenous, Chronic, BCR-ABL Positive

NCT02381379 2020-09-14

MSIT

Ministry of Health, Malaysia

Phase 3 Unknown
118 enrolled
MyeloidOther hematologic neoplasm

Leukemia, Myelogenous, Chronic, BCR-ABL Positive

NCT03978364 2019-06-07

A Study of Azacitidine for Patients With Int/High -Risk MDS and AML-MRC

Shandong Provincial Hospital

Phase 3 Unknown
100 enrolled
MyeloidOther hematologic neoplasm

Myelodysplastic Syndromes, Leukemia, Myeloid, Acute

NCT00297570 2007-10-10

Imatinib Versus Imatinib and Peg-Interferon in Patients With Ph+ CML and Complete Cytogenetic Response After Imatinib Therapy

Sheba Medical Center

Phase 3 Unknown
90 enrolled
MyeloidOther hematologic neoplasm

Leukemia, Myelogenous, Chronic, BCR-ABL Positive

Data powered by HemOnc (CC BY 4.0) Colophon âš¡